Our clients

Our clients are industrial leaders, SMEs, innovative start-ups, and institutions, operating in sectors with a strong scientific or technical component: healthcare, biotech, agrifood, energy, environment, aeronautic, space, defense, chemicals, materials, cosmetics, mobility, and others.

They trust us

  • Logo_carre_Airbus
  • Logo_carre_Bayer
  • Logo_carre_Boehringer_Ingelheim
  • Logo_carre_Inovio
  • Logo_carre_J&J
  • Logo_carre_Loreal
  • Logo_carre_Mars
  • logo_carre_michelin
  • Logo_carre_Moderna
  • Logo_carre_Nesle
  • Logo_carre_Roche
  • Logo_carre_Saint_Gobin
  • Logo_carre_Sanofi
  • Logo_carre_Solvay
  • Logo_carre_Suez
  • Logo_carre_Swarovski
  • Logo_carre_Thales
  • Logo_carre_Total_Energies

What they say

  • Client video testimonial by Mark Twyman, Senior VP and Chief Commercial Officer at Inovio Pharmaceuticals at Inovio, on the decision-making process for prioritizing therapeutic candidates, with Alcimed.
    Logo_Inovio_sans_marge

    Mark Twyman, Senior VP and Chief Commercial Officer at Inovio

    Inovio Pharmaceuticals and Alcimed co-built a structured decision-making process to evaluate and prioritize therapeutic candidates in clinical development, drawing on a benchmark of industry best practices.

  • Client testimonial by Cornelia Funk, Head of Marketing Ophthalmology at Bayer, about a competitive analysis of the German ophthalmology market to strengthen preparedness for a major competitor's market entry.
    Logo_carre_Bayer_1000

    Cornelia FUNK, Head of Marketing Ophthalmology at Bayer

    Bayer and Alcimed conducted an in-depth competitive analysis of the ophthalmology market in Germany to identify potential vulnerabilities and enhance the teams' readiness for the entry of a major competitor into the market.

  • Client video testimonial by Federico Bianco, Head of the Special Care Unit at Chiesi, about a study on the care pathway for preterm infants, with Alcimed.
    Logo_carre_Chiesi

    Federico Bianco, Head of the Special Care Unit at Chiesi

    Chiesi and Alcimed collaborated to assess the care pathway of preterm infants at higher risk of developing chronic respiratory infections later in life.

  • Client video testimonial from Bernard Cuenoud, Global Head of Research and Clinical Development at Nestlé Health Science, on mapping opportunities in rare diseases with Alcimed
    Logo_carre_Nestle_HS

    Bernard Cuenoud, Global Head of Research and Clinical Development at Nestlé Health Science

    Nestlé Health Science and Alcimed mapped opportunities in the field of rare diseases with a metabolic and nutritional component, structuring a large volume of scientific data to identify and prioritize the most promising assets for development.

  • Logo_carre_MBDA

    "We worked with Alcimed on various emerging technology themes. Alcimed enabled us to provide internal experts with a complementary watch and state of the art, an analysis of complex ecosystems, sources of inspiration from different industries, as well as the identification of the most promising partners and/or technologies. This approach improves the understanding of the dynamics of research ecosystems and guides internal concepts and investments."

    Patrice RAIPIN, Sales and Business Development for Technologies and New Products at MBDA

    MBDA and Alcimed conducted monitoring and state-of-the-art research on several emerging technologies, analyzing complex ecosystems and identifying the most promising partners and technologies to guide internal concepts and R&D investments.

  • Logo_carre_Wisamo

    "Thank you to the entire Alcimed team for embarking with us in this project and for having provided us with high-quality consulting, you are agile, committed and friendly... dream team!"

    Benoit BAISLE DAILLIEZ

    Initiative Leader, WISAMO by MICHELIN

  • Logo_carre_Air_Liquide

    "We worked with Alcimed to evaluate potential for evolution for the application markets of a gas at the core of our business. We particularly appreciated the team's investigative and analytical work, their ready availability, and their respect of our project's very tight schedule."

    Jérôme CHRISTIN

    VP Worldwide Maritime Activity